Study of the effect of Coq10 on patients with shortness of breath

Phase 3

• Conditions: J44.9; COPD Disease.; Chronic obstructive pulmonary disease, unspecified

• Registration Number: IRCT20190618043934N1
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

At least 18 years of age, no nutritional and pharmaceutical supplementation, and informed consent.

Exclusion Criteria

diagnosis of mellitus diabetes, PTE, CKD, CAD and bacterial pneumonia or taking any complementary medicines.Also diagnosis of COPD with current treatment of antioxidant medicine and supplements or any medicine that affects antioxidant storage and mitocondrial system.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum levels of antioxidants in the serum of patients. Timepoint: Before the intervention placebo and 6 weeks after starting the Coq10 capsule. Method of measurement: thiobarbituric acid method.

Secondary Outcome Measures

Name	Time	Method
Serum levels of antioxidants in the serum of patients. Timepoint: 6 weeks after taking the supplement or placebo. Method of measurement: thiobarbituric acid method.